Ontology highlight
ABSTRACT:
SUBMITTER: Kapp N
PROVIDER: S-EPMC5637897 | biostudies-other | 2017 Oct
REPOSITORIES: biostudies-other
Kapp N N Grossman D D Jackson E E Castleman L L Brahmi D D
BJOG : an international journal of obstetrics and gynaecology 20170427 11
Given the overall safety profile and increasing availability of medical pregnancy termination drugs, we asked: would the mifepristone-misoprostol regimen for medical termination at ≤10 weeks of gestation meet US Food and Drug Administration regulatory criteria for over-the-counter (OTC) approval, and if not, what are the present research gaps? We conducted a literature review of consumer behaviours necessary for a successful OTC application for medical termination at ≤10 weeks of gestation and i ...[more]